Effects and Safety of Linagliptin as an Add-on Therapy in Advanced-Stage Diabetic Nephropathy Patients Taking Renin-Angiotensin-Aldosterone System Blockers
Saved in:
Main Authors: | Yuichiro Ueda (Author), Hiroki Ishii (Author), Taisuke Kitano (Author), Mitsutoshi Shindo (Author), Haruhisa Miyazawa (Author), Kiyonori Ito (Author), Keiji Hirai (Author), Yoshio Kaku (Author), Honami Mori (Author), Taro Hoshino (Author), Susumu Ookawara (Author), Masafumi Kakei (Author), Kaoru Tabei (Author), Yoshiyuki Morishita (Author) |
---|---|
Format: | Book |
Published: |
AboutScience Srl,
2016-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effects and Safety of Linagliptin as an Add-on Therapy in Advanced-Stage Diabetic Nephropathy Patients Taking Renin-Angiotensin-Aldosterone System Blockers
by: Yuichiro Ueda, et al.
Published: (2016) -
by: Yuichiro Ueda, et al.
Published: (2016) -
Changes in urinary potassium excretion in patients with chronic kidney disease
by: Yuichiro Ueda, et al.
Published: (2016) -
Efficacy and safety of adding mizoribine to standard treatment in patients with immunoglobulin A nephropathy: A randomized controlled trial
by: Keiji Hirai, et al.
Published: (2017) -
Approximation of bicarbonate concentration using serum total carbon dioxide concentration in patients with non-dialysis chronic kidney disease
by: Keiji Hirai, et al.
Published: (2019)